Good Start Genetics®, Inc., an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability, today announced that Don Hardison, president and chief executive officer, is scheduled to present an overview of the company at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14 at 7:30 a.m. PT. The conference is being held January 13-16, 2014 at the Westin St. Francis Hotel in San Francisco.
Help employers find you! Check out all the jobs and post your resume.